Abstract:Abstract Background As the novel coronavirus triggering COVID-19 has broken out in Wuhan, China and spread rapidly worldwide, it threatens the lives of thousands of people and poses a global threat on the economies of the entire world. However, infection with COVID-19 is currently rare in children. Objective To discuss the latest findings and research focus on the basis of characteristics of children confirmed with COVID-19, and provide an insight into the future treatment and research direction. Methods We searched the terms “COVID-19 OR coronavirus OR SARS-CoV-2” AND “Pediatric OR children” on PubMed, Embase, Cochrane library, NIH, CDC, and CNKI. The authors also reviewed the guidelines published on Chinese CDC and Chinese NHC. Results We included 25 published literature references related to the epidemiology, clinical manifestation, accessary examination, treatment, and prognosis of pediatric patients with COVID-19. Conclusion The numbers of children with COVID-19 pneumonia infection are small, and most of them come from family aggregation. Symptoms are mainly mild or even asymptomatic, which allow children to be a risk factor for transmission. Thus, strict epidemiological history screening is needed for early diagnosis and segregation. This holds especially for infants, who are more susceptible to infection than other age groups in pediatric age, but have most likely subtle and unspecific symptoms. They need to be paid more attention to. CT examination is a necessity for screening the suspected cases, because most of the pediatric patients are mild cases, and plain chest X-ray do not usually show the lesions or the detailed features. Therefore, early chest CT examination combined with pathogenic detection is a recommended clinical diagnosis scheme in children. The risk factors which may suggest severe or critical progress for children are: Fast respiratory rate and/or; lethargy and drowsiness mental state and/or; lactate progressively increasing and/or; imaging showed bilateral or multi lobed infiltration, pleural effusion or rapidly expending of lesions in a short period of time and/or; less than 3 months old or those who underly diseases. For those critical pediatric patients with positive SARS-CoV-2 diagnosis, polypnea may be the most common symptom. For treatment, the elevated PCT seen in children in contrast to adults suggests that the underlying coinfection/secondary infection may be more common in pediatric patients and appropriate antibacterial treatment should be considered. Once cytokine storm is found in these patients, anti-autoimmune or blood-purifying therapy should be given in time. Furthermore, effective isolation measures and appropriate psychological comfort need to be provided timely.

Research advances in cardiovascular system damage caused by SARS-CoV-2 in children

2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases

"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment

Take Precautions Beforehand: Calling for Clinical Trials of Pediatric Drugs for Treating Coronavirus Disease 2019.

COVID-19 and the cardiovascular system: a study of pathophysiology and interpopulation variability

SARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical Management

COVID-19 and the cardiovascular system

A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19

Efficacy of Inactivated SARS-CoV-2 Vaccination in Pediatric Hematology/oncology Patients: a Real-World Study

Cardiovascular aspects of COVID-19

COVID-19 Associated Cardiovascular Disease—Risks, Prevention and Management: Heart at Risk Due to COVID-19

Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019

COVID-19 and cardiovascular complications: updates of emergency medicine

Cardiac injuries in coronavirus disease 2019 (COVID-19)

Pathogenic mechanisms of cardiovascular damage in COVID-19

Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Project

Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

COVID-19 pathophysiology: A review